Paul Vanden Branden, director and product manager at laboratory equipment supplier SciMed, examines the potential of supercritical CO₂ to supplant environmentally harmful solvent in extractions and separations

The environmental and financial challenges associated with widely used organic solvents are severe. To reach sustainability goals, laboratories around the world must wean themselves off these long relied-upon hydrocarbons and pursue greener alternatives.

Following on from a decision last year to evaluate options to boost value, the board of Labcorp has authorised a spin-off of its clinical development business to shareholders through a tax-free transaction. This should be completed in 2H 2023.

LabCorp is expected to continue being publicly traded on the New York Stock Exchange and the clinical development business should also be publicly listed. This will lead to the creation of two independent companies with “distinct strategic priorities, customer needs and value creation”, the company said: